Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial. [electronic resource]
Producer: 20131101Description: 417-26 p. digitalISSN:- 1520-7560
- Adamantane -- adverse effects
- Aged
- Biomarkers -- blood
- Body Mass Index
- Cardiovascular Diseases -- chemically induced
- Diabetes Mellitus, Type 2 -- blood
- Diabetic Angiopathies -- epidemiology
- Diabetic Nephropathies -- epidemiology
- Dipeptides -- adverse effects
- Dipeptidyl-Peptidase IV Inhibitors -- adverse effects
- Drug Therapy, Combination -- adverse effects
- Female
- Humans
- Hyperglycemia -- epidemiology
- Hypoglycemic Agents -- adverse effects
- Insulin Resistance
- Male
- Middle Aged
- Overweight -- complications
- Prevalence
- Risk Factors
- Severity of Illness Index
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.